CN1057834A - 用于治疗与白三烯有关的疾病的酰胺连接的吡啶-苯甲酸衍生物 - Google Patents

用于治疗与白三烯有关的疾病的酰胺连接的吡啶-苯甲酸衍生物 Download PDF

Info

Publication number
CN1057834A
CN1057834A CN91104852A CN91104852A CN1057834A CN 1057834 A CN1057834 A CN 1057834A CN 91104852 A CN91104852 A CN 91104852A CN 91104852 A CN91104852 A CN 91104852A CN 1057834 A CN1057834 A CN 1057834A
Authority
CN
China
Prior art keywords
phenyl
compound
salt
pharmaceutically acceptable
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN91104852A
Other languages
English (en)
Chinese (zh)
Inventor
R·A·戴恩斯
W·D·金斯伯里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of CN1057834A publication Critical patent/CN1057834A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN91104852A 1990-06-07 1991-06-07 用于治疗与白三烯有关的疾病的酰胺连接的吡啶-苯甲酸衍生物 Pending CN1057834A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53438790A 1990-06-07 1990-06-07
US534,387 1990-06-07

Publications (1)

Publication Number Publication Date
CN1057834A true CN1057834A (zh) 1992-01-15

Family

ID=24129827

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91104852A Pending CN1057834A (zh) 1990-06-07 1991-06-07 用于治疗与白三烯有关的疾病的酰胺连接的吡啶-苯甲酸衍生物

Country Status (14)

Country Link
EP (1) EP0532621A1 (fr)
JP (1) JPH05507698A (fr)
KR (1) KR930700448A (fr)
CN (1) CN1057834A (fr)
AU (1) AU7982591A (fr)
CA (1) CA2083956A1 (fr)
FI (1) FI925546A0 (fr)
HU (1) HUT64521A (fr)
IE (1) IE911938A1 (fr)
IL (1) IL98412A0 (fr)
MA (1) MA22197A1 (fr)
PT (1) PT97911A (fr)
WO (1) WO1991018883A1 (fr)
ZA (1) ZA914369B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060758A (zh) * 2010-12-21 2011-05-18 杭州师范大学 一种4-苄氧基-吡啶-2-酮的制备方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
ES2065234B1 (es) * 1992-10-27 1995-09-01 Smithkline Beecham Corp Compuestos para tratar enfermedades relacionadas con los leucotrienos.
AU4557397A (en) 1996-09-26 1998-04-17 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555520A (en) * 1984-08-20 1985-11-26 E. R. Squibb & Sons, Inc. 2-Pyridylcarboxamides which inhibit arachidonic acid release

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060758A (zh) * 2010-12-21 2011-05-18 杭州师范大学 一种4-苄氧基-吡啶-2-酮的制备方法
CN102060758B (zh) * 2010-12-21 2012-12-05 杭州师范大学 一种4-苄氧基-吡啶-2-酮的制备方法

Also Published As

Publication number Publication date
IL98412A0 (en) 1992-07-15
HUT64521A (en) 1994-01-28
CA2083956A1 (fr) 1991-12-08
EP0532621A1 (fr) 1993-03-24
IE911938A1 (en) 1991-12-18
KR930700448A (ko) 1993-03-15
FI925546A (fi) 1992-12-07
HU9203868D0 (en) 1993-03-29
JPH05507698A (ja) 1993-11-04
WO1991018883A1 (fr) 1991-12-12
FI925546A0 (fi) 1992-12-07
PT97911A (pt) 1992-03-31
AU7982591A (en) 1991-12-31
ZA914369B (en) 1992-06-24
MA22197A1 (fr) 1992-04-01

Similar Documents

Publication Publication Date Title
CN1191236C (zh) 取代的6,6－杂－双环衍生物
CN1050605C (zh) 环烷并吲哚和环烷并氮杂吲哚衍生物,其制备方法和含有它们的药物组合物
CN1094490C (zh) 作为血清素拮抗剂的喹诺－2(1h)－酮衍生物
CN1374953A (zh) 含氮的6－员芳香环化合物
CN1688548A (zh) 喹啉抗生素中间体的制备方法
CN1411445A (zh) 3－羟基吡啶甲酸衍生物的制备方法
CN1036393C (zh) 7-(2-氨乙基)-苯并噻唑酮
CN1126468A (zh) 氟烷氧基取代的苯甲酰胺类及其作为环状核苷酸磷酸二酯酶抑制剂的应用
CN1422269A (zh) 1h－咪唑并吡啶衍生物
CN101035761A (zh) 作为聚(adp-核糖)聚合酶(parp)抑制剂、治疗由坏死或细胞程序死亡导致的组织损伤或疾病的3，6－取代的5－芳基氨基－1h－吡啶－2－酮衍生物和相关化合物
CN1244867A (zh) 作为p38蛋白激酶抑制剂的取代的含氮杂环
CN1246857A (zh) 取代的嘧啶酮和吡啶酮化合物和它们的应用
CN1191533A (zh) 作为神经激肽受体拮抗剂的1－苯甲酰基－2－(吲哚基－3－烷基)－哌嗪衍生物
CN1168709C (zh) 作为基质金属蛋白酶抑制剂的β-磺酰基异羟肟酸的α-羟基、-氨基和卤代衍生物
CN1234797A (zh) N－取代的氮杂环化合物
CN1910154A (zh) 用作分枝杆菌抑制剂的喹啉衍生物
CN1265098A (zh) 抑制因子xa的杂环衍生物
CN1206407A (zh) 取代的乙烯基吡啶衍生物和含有它们的药物
CN1113235A (zh) 苯并咪唑、含这些化合物的药物组合物和其制备方法
CN1153517A (zh) 新的喹喔啉二酮衍生物、其制备方法和作为药物的应用
US20020173661A1 (en) Tri-aryl-substituted-ethane PDE4 inhibitors
CN1726196A (zh) 基于吡嗪的微管蛋白抑制剂
CN1176908C (zh) 制备吡啶衍生物的方法
CN1033800A (zh) 茚满衍生物和其制备方法
CN1058015A (zh) 苯甲酸衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication